PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surg…
Medical - Devices
US, Redwood City [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -23.80 | -85.14 | -68.78 | |
| Graham Fair Price | -6.57 | 7.70 | 8.24 | |
| PEG | 26.87 | 4.16 | -3.28 | |
| Price/Book | 20.23 | 9.08 | 7.55 | |
| Price/Cash Flow | -10.69 | -70.04 | -63.27 | |
| Prices/Earnings | -19.82 | -23.09 | -19.27 | |
| Price/Sales | 10.65 | 53.83 | 48.65 | |
| Price/FCF | -10.69 | -70.04 | -63.27 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 22.86 | 0.56 | 0.46 | |
| Operating Margin | 8.47 | -0.62 | -0.68 | |
| ROA | 0.25 | -0.07 | -0.07 | |
| ROE | -0.10 | -0.10 | -0.35 | |
| ROIC | -0.09 | -0.09 | 7.69 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.03 | < 0.005 | 310.79 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | -0.15 | 0.06 | -58.13 | |
| EPS QOQ | -0.06 | 0.06 | -5.56 | |
| FCF QOQ | -0.36 | -0.02 | 93.92 | |
| Revenue QOQ | 0.24 | 0.02 | -90.90 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 151.33 | 192.05 | 26.91 | |
| Days Sales Outstanding (DSO) | 99.90 | 113.32 | 13.43 | |
| Inventory Turnover | 0.59 | 0.47 | -21.20 | |
| Debt/Capitalization | 0.16 | 0.17 | 5.35 | |
| Quick Ratio | 6.65 | 7.29 | 9.52 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 5.55 | 5.18 | -6.73 | |
| Cash | 5.08 | 4.42 | -13.03 | |
| Capex | -0.17 | -0.04 | 77.86 | |
| Free Cash Flow | -0.66 | -0.67 | -1.32 | |
| Revenue | 0.86 | 0.87 | 1.35 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad